Cancer blandt gigtpatienter behandlet med tumornekrosefaktor-alfa-haemmere

Lene Dreyer, Lene Mellemkjaer, Merete Lund Hetland

    9 Citationer (Scopus)

    Abstract

    The use of anti-tumour necrosis factor (anti-TNF) therapy is increasing in the treatment of rheumatoid arthritis (RA), spondyloarthropathy, psoriasis and inflammatory bowel disease. It is being debated whether treatment of patients with rheumatic diseases with anti-TNF therapy is associated with an increased cancer incidence.
    Bidragets oversatte titel[Cancer in arthritis patients after anti-tumour necrosis factor therapy]
    OriginalsprogDansk
    TidsskriftUgeskrift for Laeger
    Vol/bind171
    Udgave nummer7
    Sider (fra-til)506-11
    Antal sider6
    ISSN0041-5782
    StatusUdgivet - 2009

    Emneord

    • Adult
    • Aged
    • Antibodies, Monoclonal
    • Antibodies, Monoclonal, Humanized
    • Antirheumatic Agents
    • Arthritis, Rheumatoid
    • Databases, Factual
    • Denmark
    • Female
    • Humans
    • Immunoglobulin G
    • Male
    • Middle Aged
    • Neoplasms
    • Receptors, Tumor Necrosis Factor
    • Registries
    • Risk Factors
    • Spondylitis, Ankylosing

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Cancer blandt gigtpatienter behandlet med tumornekrosefaktor-alfa-haemmere'. Sammen danner de et unikt fingeraftryk.

    Citationsformater